tiprankstipranks
KOREA UNITED PHARM, INC. (KR:033270)
:033270
South Korea Market
033270
KOREA UNITED PHARM, INC.
RESEARCH TOOLSreports

KOREA UNITED PHARM, INC. (033270) Financial Statements

― Followers

KOREA UNITED PHARM, INC. Financial Overview

KOREA UNITED PHARM, INC.'s market cap is currently ₩258.99B. The company's EPS TTM is ₩2633.27; its P/E ratio is 6.78; KOREA UNITED PHARM, INC. is scheduled to report earnings on July 30, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 288.76B₩ 288.71B₩ 278.94B₩ 262.52B₩ 221.04B
Gross Profit₩ 175.41B₩ 163.97B₩ 158.98B₩ 145.29B₩ 122.66B
Operating Income₩ 48.91B₩ 56.28B₩ 54.95B₩ 48.21B₩ 33.23B
EBITDA₩ 60.47B₩ 57.84B₩ 70.78B₩ 61.77B₩ 46.61B
Net Income₩ 38.31B₩ 32.45B₩ 48.26B₩ 45.28B₩ 28.65B
Balance Sheet
Cash & Short-Term Investments₩ 157.07B₩ 132.32B₩ 151.05B₩ 142.63B₩ 123.20B
Total Assets₩ 519.49B₩ 473.93B₩ 468.86B₩ 417.89B₩ 380.03B
Total Debt₩ 14.02B₩ 15.65B₩ 40.34B₩ 30.30B₩ 32.99B
Net Debt₩ -26.27B₩ -18.05B₩ 16.43B₩ 3.40B₩ -27.84B
Total Liabilities₩ 64.82B₩ 67.72B₩ 90.18B₩ 80.03B₩ 79.32B
Stockholders' Equity₩ 454.63B₩ 406.21B₩ 378.68B₩ 337.86B₩ 300.71B
Cash Flow
Free Cash Flow₩ 27.70B₩ 5.57B₩ 19.34B₩ 39.57B₩ 31.30B
Operating Cash Flow₩ 51.14B₩ 26.79B₩ 50.65B₩ 63.78B₩ 44.09B
Investing Cash Flow₩ -41.07B₩ 11.70B₩ -56.41B₩ -87.90B₩ -17.70B
Financing Cash Flow₩ -3.63B₩ -29.46B₩ 2.55B₩ -10.59B₩ -8.20B
Currency in KRW

KOREA UNITED PHARM, INC. Earnings and Revenue History

Income Statement >

KOREA UNITED PHARM, INC. Debt to Assets

Balance Sheet >

KOREA UNITED PHARM, INC. Cash Flow

Cash Flow >

KOREA UNITED PHARM, INC. Forecast EPS vs Actual EPS

Earnings >